Skip to Content

Pfizer PBC 125 (Ibrance 125 mg)

Generic Name: palbociclib

This pill with imprint "Pfizer PBC 125" is Tan, Capsule-shape and has been identified as Ibrance 125 mg. It is supplied by Pfizer Inc..

Ibrance is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug class CDK 4/6 inhibitors. Ibrance 125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for Pfizer PBC 125

Ibrance

Generic Name:
palbociclib
Imprint:
Pfizer PBC 125
Strength:
125 mg
Color:
Tan
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CDK 4/6 inhibitors
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Pfizer Inc.
National Drug Code (NDC):
00069-0189

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide